Entity type
Company
Filer Snapshot
JOHNSON & JOHNSON
CIK 0000200406. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
232
Latest filing
12 Jun 2026
Industry
Pharmaceutical Preparations
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: 13F-HR for Q1 2026. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
$652.36M
16 holdings for Q1 2026
Open portfolioLargest parsed holding
PTGX
$258.14M reported value
Open holding13D/G large stake
RLYB
31 Mar 2026 · 2.9% ownership
Open 13D/GInsider / owner context
KVUE
23 Aug 2023 · $4.19B
Open owner pageSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Forms 3/4/5
View source filing
4 filed on 12 Jun 2026 for CIK 0000200406.
- Listed symbols
- JNJ on NYSE
- Parsed SEC ownership signals
-
Parsed SEC ownership coverage
These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.
13F portfolio$652.36MQuarterly institutional holdings reported on Form 13F.
Forms 3/4/5 positions$4.3BReporting-owner positions with enough filing detail to estimate value.
Latest reported 13F value
13F$652.36MReported market value from the latest parsed Form 13F information table; this is not total assets under management.
Forms 3/4/5 position value
3/4/5$4.3BEstimated from parsed Forms 3/4/5 when filings include enough share and price data.
Largest 13F holdings
13FPTGX NBTX MGTX RAPP CVRX+11 more
CTNM LEGN XNCR PRCT FATE NMRA RLYB VOR LAB NNOX ACETLargest symbols in the latest parsed Form 13F information table.
Largest linked holdings
Largest issuer positions linked to this CIK across parsed 13F, 13D/G, and Forms 3/4/5 records.
KVUE MGTX CVRX CTNMLargest 13F holdings
Largest symbols in the latest parsed Form 13F information table.
PTGX NBTX MGTX RAPP CVRX CTNM LEGN XNCR+8 more
PRCT FATE NMRA RLYB VOR LAB NNOX ACETLargest active 13G stakes
Passive or institutional large-stake positions disclosed in parsed Schedule 13G filings.
RAPP CVRX RLYBHow to read these SEC ownership signals
- Read each filing family separately: 13F portfolios, 13D/G large stakes, and Forms 3/4/5 owner positions answer different SEC disclosure questions.
- Open the linked research path when you need the filing, CIK, issuer, or CUSIP trail behind a value.
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- One Johnson & Johnson Plz, New Brunswick, NJ, 08933
- Incorporated in
- NJ
- Fiscal year end
- 03 January
- Former names on EDGAR
- JOHNSON & JOHNSON ET AL (to 23 Jan 1996)
Ownership signals
CIK-linked ownership evidence from parsed SEC filings.
1 signal
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Filer intelligence
What SEC filings say about JOHNSON & JOHNSON
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- Latest parsed 13F shows $652.36M across 16 reported holdings for Q1 2026.
- Largest parsed 13F holding: PTGX at $258.14M.
- 3 recent 13D/G stake rows found; top row is RLYB at 2.9% ownership.
- Forms 3/4/5 show insider context for KVUE worth $4.19B.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
Top parsed 13F holdings
Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.
Top 5 concentration
89%
Share of latest parsed 13F value represented by the visible holdings below.
Top 5 reported value
$583.18M
Compared with $652.36M total 13F value.
Top 5 net change
$0
Position-value change inside the visible top holdings only.
13F concentration map
A simple visual split of the latest parsed 13F portfolio.
Largest add: RLYB · Largest trim: RLYB
PTGX
NBTX
MGTX
RAPP
CVRX
Other holdings
13D/G large-stake context
RLYB
31 Mar 2026 · Common Stock, $0.0001 par value
CVRX
31 Dec 2025 · Common Stock, $0.01 par value
RAPP
30 Sep 2025 · Common Stock, $0.001 par value
Forms 3/4/5 insider context
KVUE
23 Aug 2023 · 10% owner
MGTX
09 Nov 2022 · 10% owner
CVRX
26 Nov 2025 · 10% owner
CTNM
09 Apr 2024 · 10% owner
Latest update
What changed recently for JOHNSON & JOHNSON
Latest 13F period: Q1 2026. Open the source-backed page to inspect the fresh filing or facts context.
Update date
13 May 2026
Page type
Filer profile
Latest period
Q1 2026
Institutional portfolio context was refreshed from a 13F filing filed on 13 May 2026.
Benchmark Context
Benchmark context for this company
JOHNSON & JOHNSON has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest 13F period: Q1 2026. That gives you a fresh baseline before you compare this company with peers.
- Latest company facts filing date: 22 Apr 2026.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
SEC filing record
CIK 0000200406 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
232
First seen
14 Feb 2020
Latest filing
12 Jun 2026
Entity
Company
Observed form types
10-K
10-Q
13F-HR
13F-HR/A
13F-NT
3
3/A
4
4/A
5
+1 more
Industry context: Pharmaceutical Preparations.
Latest Filings
Showing the latest 12 of 232 SEC filings for JOHNSON & JOHNSON.
4
4 filing
- Filing date
- 12 Jun 2026
- Reporting date
- 11 Jun 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 11 Jun 2026
- Reporting date
- 09 Jun 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 11 Jun 2026
- Reporting date
- 09 Jun 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 11 Jun 2026
- Reporting date
- 09 Jun 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
13F-HR
13F-HR filing
- Filing date
- 13 May 2026
- Reporting date
- 31 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 04 May 2026
- Reporting date
- 01 May 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 27 Apr 2026
- Reporting date
- 23 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 27 Apr 2026
- Reporting date
- 23 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 27 Apr 2026
- Reporting date
- 23 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 27 Apr 2026
- Reporting date
- 23 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 27 Apr 2026
- Reporting date
- 23 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 27 Apr 2026
- Reporting date
- 23 Apr 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing